Showing codes J9229 (Injection, inotuzumab ozogamicin, 0.1 mg) — J9293 (Injection, mitoxantrone hydrochloride, per 5 mg)

J9229 - Inj inotuzumab ozogam 0.1 mg
Long description: Injection, inotuzumab ozogamicin, 0.1 mg
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9230 - Mechlorethamine hcl inj
Long description: Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg
Code added date: 19860101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9245 - Inj melpha hydroch nos 50 mg
Long description: Injection, melphalan hydrochloride, not otherwise specified, 50 mg
Code added date: 19950101.
Code effective date: 20200701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9246 - Inj., evomela, 1 mg
Long description: Injection, melphalan (evomela), 1 mg
Code added date: 20200701.
Code effective date: 20200701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9247 - Inj, melphalan flufenami 1mg
Long description: Injection, melphalan flufenamide, 1mg
Code added date: 20211001.
Code effective date: 20211001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9248 - Inj melphalan (hepzato) 1 mg
Long description: Injection, melphalan (hepzato), 1 mg
Code added date: 20240401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9249 - Inj, melphalan (apotex) 1 mg
Long description: Injection, melphalan (apotex), 1 mg
Code added date: 20240401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9250 - Methotrexate sodium inj
Long description: Methotrexate sodium, 5 mg
Code added date: 19940101.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9255 - Inj, methotrexate (accord)
Long description: Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg
Code added date: 20240101.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9258 - Paclitaxel (teva)
Long description: Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg
Code added date: 20240101.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9259 - Paclitaxel (american regent)
Long description: Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg
Code added date: 20230701.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9260 - Inj methotrexate sodium 50mg
Long description: Injection, methotrexate sodium, 50 mg
Code added date: 19840101.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9261 - Nelarabine injection
Long description: Injection, nelarabine, 50 mg
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9262 - Inj, omacetaxine mep, 0.01mg
Long description: Injection, omacetaxine mepesuccinate, 0.01 mg
Code added date: 20140101.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9263 - Oxaliplatin
Long description: Injection, oxaliplatin, 0.5 mg
Code added date: 20040101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9264 - Paclitaxel protein bound
Long description: Injection, paclitaxel protein-bound particles, 1 mg
Code added date: 20060101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9265 - Paclitaxel injection
Long description: Injection, paclitaxel, 30 mg
Code added date: 19940101.
Code effective date: 20150101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9266 - Pegaspargase injection
Long description: Injection, pegaspargase, per single dose vial
Code added date: 19960101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9267 - Paclitaxel injection
Long description: Injection, paclitaxel, 1 mg
Code added date: 20150101.
Code effective date: 20150101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9268 - Pentostatin injection
Long description: Injection, pentostatin, 10 mg
Code added date: 19940101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9269 - Inj. tagraxofusp-erzs 10 mcg
Long description: Injection, tagraxofusp-erzs, 10 micrograms
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9270 - Plicamycin (mithramycin) inj
Long description: Injection, plicamycin, 2.5 mg
Code added date: 19840101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9271 - Inj pembrolizumab
Long description: Injection, pembrolizumab, 1 mg
Code added date: 20160101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9272 - Inj, dostarlimab-gxly, 10 mg
Long description: Injection, dostarlimab-gxly, 10 mg
Code added date: 20220101.
Code effective date: 20220101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9273 - Inj tisotu vedotin-tftv, 1mg
Long description: Injection, tisotumab vedotin-tftv, 1 mg
Code added date: 20220401.
Code effective date: 20220401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9274 - Inj, tebentafusp-tebn, 1 mcg
Long description: Injection, tebentafusp-tebn, 1 microgram
Code added date: 20221001.
Code effective date: 20221001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9280 - Mitomycin injection
Long description: Injection, mitomycin, 5 mg
Code added date: 19860101.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9281 - Mitomycin instillation
Long description: Mitomycin pyelocalyceal instillation, 1 mg
Code added date: 20210101.
Code effective date: 20210101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9285 - Inj, olaratumab, 10 mg
Long description: Injection, olaratumab, 10 mg
Code added date: 20180101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9286 - Inj glofitamab gxbm, 2.5 mg
Long description: Injection, glofitamab-gxbm, 2.5 mg
Code added date: 20240101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9293 - Mitoxantrone hydrochl / 5 mg
Long description: Injection, mitoxantrone hydrochloride, per 5 mg
Code added date: 19900101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF